Blood component interactions with polysaccharide biomaterials for vascular applications. Heart disease is the major killer of people in Australia and the Western world. It is due mainly to the blockage of vessels supplying the muscle of the heart with blood and nutrients, which can be replaced or by-passed but the supply of native vessels in the body is limited. Tissue engineering laboratories have been trying to develop blood vessels for this use for many years without significant success. T ....Blood component interactions with polysaccharide biomaterials for vascular applications. Heart disease is the major killer of people in Australia and the Western world. It is due mainly to the blockage of vessels supplying the muscle of the heart with blood and nutrients, which can be replaced or by-passed but the supply of native vessels in the body is limited. Tissue engineering laboratories have been trying to develop blood vessels for this use for many years without significant success. This application plans to understand the molecular signals contained within the sugar sequences used in a commonly used biomaterial chitosan that may be used in the construction of synthetic vascular grafts. If we can understand how blood cells interact with this biomaterial, we may be able to develop a blood vessel in the laboratory.Read moreRead less
Switching the light on cartilage repair. Osteoarthritis is a leading cause of pain and disability in adults and affects 15 per cent of the Australian population. This project will develop a revolutionary new approach to treat joint disorders using smart materials and stem cells. The novel materials and techniques developed will help Australia maintain its leading edge in biotechnology.
Assessing Bone Quality and Health: Experimental imaging, structural characterisation, and mechanical modelling of bone in 3D. Age-related bone fractures due to osteoporosis impose a significant social and economic problem on our increasingly aging population. The assessment of bone quality is important in the diagnosis of age related bone fragility and for studying the efficacy of therapeutic intervens. In this proposal a unique interdisciplinary group with expertise in bone and mineral research ....Assessing Bone Quality and Health: Experimental imaging, structural characterisation, and mechanical modelling of bone in 3D. Age-related bone fractures due to osteoporosis impose a significant social and economic problem on our increasingly aging population. The assessment of bone quality is important in the diagnosis of age related bone fragility and for studying the efficacy of therapeutic intervens. In this proposal a unique interdisciplinary group with expertise in bone and mineral research, experimental 3D imaging and the characterisation and modelling of complex materials will tackle the problem of assessing bone quality and health. The proposed research will greatly improve our assessment of the mechanical competence of bone.Read moreRead less
Industrial Transformation Training Centres - Grant ID: IC170100016
Funder
Australian Research Council
Funding Amount
$3,123,492.00
Summary
ARC Training Centre for Personalised Therapeutics Technologies. The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries. By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therap ....ARC Training Centre for Personalised Therapeutics Technologies. The ARC Training Centre for Personalised Therapeutics Technologies aims to create and develop the skills and technology to benefit from the transformative impacts that cell/organ-on-a-chip technology will have on the medtech/pharma industries. By combining microfluidics-based/real-time technologies with personalised medicine the Training Centre will provide industry growth opportunities through improved screening of potential therapeutics. The use of an individual patient’s cellular and molecular research findings will ultimately enable personalised diagnostic and therapeutic decisions.Read moreRead less
Tissue-like, nonlinearly elastic nanobiomaterials for soft tissue regeneration. The purpose of this project is to advance the discipline of soft tissue engineering and regeneration with novel biomaterials, nanotechnology and novel clinical treatment concepts. The key outcomes include new elastic tissue-like nanobiomaterials, new varieties of medical implants and innovative treatment methodology.
NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and ....NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and then polymerising the micelles in a biodegradable polymer scaffold. This would enable local delivery of osteogenic growth factors to a bone defect.Read moreRead less
Nanoparticle formulations for DNA-targeted radiotherapy and imaging: combinations with chromatin-modifying compounds. This project will develop a new approach for treating and imaging cancer using nanoparticles which target specific cells for cancer therapy and diagnostic imaging. The nanoparticles will be combined with compounds that alter the architecture of DNA to make therapy more effective and to improve the safety of imaging.
Structural design of third generation biomaterials. This project will design third generation biomaterials for heart valves, cartilage and bones that guide the formation of new tissue whilst being dissolved inside the human body. As a result, it is anticipated that painful and costly revision surgery will become obsolete. Major benefits will be achieved in paediatric health as implants will have the ability to grow with the child.
Australian Laureate Fellowships - Grant ID: FL110100196
Funder
Australian Research Council
Funding Amount
$2,638,208.00
Summary
New dimensions in organic bionics. The advent of the next generation of medical bionic devices is critically dependent on advances in multifunctional organic materials that, like living systems, provide spatial and temporal control. These advances will provide a platform to revolutionise medical treatments such as nerve and muscle regeneration, with impact on neural prosthetics.
Synthetic extracellular matrices for control of cellular reprogramming. This project aims to design materials that control the cellular environment for the fast, efficient, and reproducible production of reprogrammed cells in embryo-like architectures. Regenerative medicine has entered a new era, where reprogramming a patient’s cells is now possible for studying and treating disease. The expected outcomes of this project include mechanistic details of cell reprogramming, design rules for 3D prin ....Synthetic extracellular matrices for control of cellular reprogramming. This project aims to design materials that control the cellular environment for the fast, efficient, and reproducible production of reprogrammed cells in embryo-like architectures. Regenerative medicine has entered a new era, where reprogramming a patient’s cells is now possible for studying and treating disease. The expected outcomes of this project include mechanistic details of cell reprogramming, design rules for 3D printing of living cells and commercially viable reprogramming materials. The project expects to contribute fundamental knowledge in materials and biomedical sciences, while providing tools that will benefit commercial ventures in cell and tissue manufacturing.Read moreRead less